SlideShare uma empresa Scribd logo
1 de 21
Mrs. Rishita D Patel
 Rheumatoid arthritis (RA) is a chronic inflammatory disorder of
autoimmune origin that may affect many tissues and organs but
principally attacks the joints,
producing a nonsuppurative proliferative and inflammatory synovitis.
 RA often progresses to destruction of the articular cartilage and ankylosis
of the joints.
 Extraarticular lesions may involve skin, heart, blood vessels and lungs.
 The prevalence in the United States is approximately 1%.
 In India, estimated prevalence rate of RA is 0.5%–0.75%.[25-Aug-2020]
 The disease peaks in the second to fourth decades and is three times more
common in women than men.
 systemic manifestations include haematologic, pulmonary, neurological and
cardiovascular abnormalities.
 ETIOPATHOGENESIS
On based on etiology and pathogenesis proposes that RA occurs in an immunogenetically
predisposed individual
to the effect of microbial agents acting as trigger antigen.
The role of superantigens which are produced by several microorganisms with capacity to
bind to susceptible gene [HLA-DR molecules (MHC-II region)] has also emerged.
 A number of observations in research indicates the role of immune processes,
particularly autoimmune phenomenon, in the development of RA. These include the
following:
1. Detection of circulating autoantibody called rheumatoid factor (RF) against Fc
portion of autologous IgG in about 80% cases of RA.
RF antibodies are heterogeneous and consist of IgM and IgG class.
2. The presence of antigen-antibody complexes (IgG-RF complexes) in the circulation as
well as in the synovial fluid.
3. The presence of other autoantibodies such as antinuclear factor (ANF), antibodies
to collagen type II, and antibodies to cytoskeleton.
4. Antigenicity of proteoglycans of human articular cartilage.
5. The presence of g-globulin, particularly IgG and IgM, in the synovial fluid.
6. Association of RA with amyloidosis.
7. Activation of cell-mediated immunity as observed by presence of numerous
inflammatory cells in the synovium, chiefly CD4+ T lymphocytes and some
macrophages.
 Though the above hypothesis of a possible role of autoimmunity in the etiology and
pathogenesis of RA is generally widely accepted, controversy continues as regards the
trigger events which initiate the destruction of articular cartilage. Various
possibilities which have been suggested are as follows:
1. The existence of an infectious agent such as mycoplasma, Epstein-Barr virus
(EBV), cytomegalovirus (CMV) or rubella virus, either locally in the synovial
fluid or systemic infection some time prior to the attack of RA.
1. The possible role of HLA-DR4 and HLA-DR1 in initiation of immunologic damage.
i) In response to antigenic exposure (e.g. infectious agent) in a genetically
predisposed individual (HLA-DR), CD4+ T-cells are activated.
ii) These cells elaborate cytokines, the important ones being tumour necrosis
factor (TNF)-a, interferon (IF)-g, interleukin (IL)-1 and IL-6.
iii) These cytokines activate endothelial cells, B lymphocytes and macrophages.
iv) Activation of B-cells releases IgM antibody against IgG (i.e. anti-IgG); this
molecule is termed rheumatoid factor (RF).
v) IgG and IgM immune complexes trigger inflammatory damage to the synovium,
small blood vessels and collagen.
vi) Activated endothelial cells express adhesion molecules which stimulate collection
of inflammatory cells.
vii)Activation of macrophages releases more cytokines which cause damage to joint
tissues and vascularisation of cartilage termed pannus formation.
viii)Eventually damage and destruction of bone and cartilage are followed by fibrosis
and ankylosis producing joint deformities.
 The predominant pathologic lesions are found in the joints and tendons, and less often,
extra-articular lesions are encountered.
 ARTICULAR LESIONS
RA involves first the small joints of hands and feet and then symmetrically affects the
joints of wrists, elbows, ankles and knees.
The proximal interphalangeal and metacarpophalangeal joints are affected most
severely.
Frequently cervical spine is involved but lumbar spine is spared
 The characteristic feature is diffuse proliferative synovitis with formation of pannus.
The microscopic changes are as under
1. Numerous folds of large villi of synovium.
2. Marked thickening of the synovial membrane due to oedema, congestion and
multilayering of synoviocytes.
3. Intense inflammatory cell infiltrate in the synovial membrane with predominance of
lymphocytes, plasma cells and some macrophages, at places forming lymphoid
follicles.
4. Foci of fibrinoid necrosis and fibrin deposition.
 The pannus progressively destroys the underlying cartilage and subchondral bone.
 This invasion of pannus results in demineralisation and cystic resorption of
underlying bone.
 Later, fibrous adhesions or even bony ankylosis may unite the two opposing joint
surfaces.
 In addition, persistent inflammation causes weakening and even rupture of the
tendons.
 Nonspecific inflammatory changes are seen in the blood vessels (acute vasculitis),
lungs, pleura, pericardium, myocardium, lymph nodes, peripheral nerves and eyes.
 But one of the characteristic extra-articular manifestation of RA is occurrence of
rheumatoid nodules in the skin.
 Rheumatoid nodules are particularly found in the subcutaneous tissue over pressure
points such as the elbows, occiput and sacrum.
 Similar nodules may be found in the lung parenchyma, pleura, heart valves,
myocardium and other internal organs.
1. Juvenile RA found in adolescent patients under 16 years of age is characterised by
acute onset of fever and predominant involvement of knees and ankles. Pathologic
changes are similar but RF is rarely present.
1. Felty’s syndrome consists of polyarticular RA associated with splenomegaly and
hypersplenism and consequent haematologic derangements.
2. Ankylosing spondylitis or rheumatoid spondylitis is rheumatoid involvement of the
spine, particularly sacroiliac joints, in young male patients. The condition has a
strong HLA-B27 association and may have associated inflammatory diseases such
as inflammatory bowel disease, anterior uveitis and Reiter’s syndrome.
Rheumatoid arthritis _RDP

Mais conteúdo relacionado

Mais procurados

Process of Inflammation & Repair.pptx
Process of Inflammation & Repair.pptxProcess of Inflammation & Repair.pptx
Process of Inflammation & Repair.pptxShikhaSachde
 
Rheumatoid arthritis
Rheumatoid arthritis Rheumatoid arthritis
Rheumatoid arthritis Harsh Chunara
 
Structure and function of erythropoietic tissue
Structure and function of erythropoietic tissueStructure and function of erythropoietic tissue
Structure and function of erythropoietic tissueJuan Carlos Munévar
 
Drug interactions in pharmacy related practice j. bolt
Drug interactions in pharmacy related practice j. boltDrug interactions in pharmacy related practice j. bolt
Drug interactions in pharmacy related practice j. boltPASaskatchewan
 
Inflammatory Bowel disease ankita
Inflammatory Bowel disease ankitaInflammatory Bowel disease ankita
Inflammatory Bowel disease ankitaankitamishra1402
 
INFLAMMATORY BOWEL DISEASES
INFLAMMATORY BOWEL DISEASESINFLAMMATORY BOWEL DISEASES
INFLAMMATORY BOWEL DISEASESPriyansha Singh
 
1. inflammation with vascular events dr ashutosh kumar
1. inflammation  with vascular events dr ashutosh kumar1. inflammation  with vascular events dr ashutosh kumar
1. inflammation with vascular events dr ashutosh kumarDrAshutosh Kumar
 
Lecture 19 pancreatitis - Pathology
Lecture 19 pancreatitis - PathologyLecture 19 pancreatitis - Pathology
Lecture 19 pancreatitis - PathologyAreej Abu Hanieh
 
Metabolic Bone Diseases Current Concept
Metabolic Bone Diseases Current ConceptMetabolic Bone Diseases Current Concept
Metabolic Bone Diseases Current Conceptvinod naneria
 
Peptic ulcer. rubel ppt
Peptic ulcer. rubel pptPeptic ulcer. rubel ppt
Peptic ulcer. rubel pptrubel2003
 
Inflammatory Bowel Disease
Inflammatory Bowel DiseaseInflammatory Bowel Disease
Inflammatory Bowel DiseaseHossam Ghoneim
 
Collagen Biochemistry
Collagen BiochemistryCollagen Biochemistry
Collagen Biochemistrycarcrash123
 
Irritable Bowel Syndrome: An Update in Pathophysiology and Management
Irritable Bowel Syndrome: An Update in Pathophysiology and Management Irritable Bowel Syndrome: An Update in Pathophysiology and Management
Irritable Bowel Syndrome: An Update in Pathophysiology and Management Monkez M Yousif
 
Inflammatory Bowel Disease
Inflammatory Bowel DiseaseInflammatory Bowel Disease
Inflammatory Bowel Disease27168593
 

Mais procurados (20)

Process of Inflammation & Repair.pptx
Process of Inflammation & Repair.pptxProcess of Inflammation & Repair.pptx
Process of Inflammation & Repair.pptx
 
Rheumatoid arthritis
Rheumatoid arthritis Rheumatoid arthritis
Rheumatoid arthritis
 
LIVER FUNCTIONS TESTS -2-
LIVER FUNCTIONS TESTS -2-LIVER FUNCTIONS TESTS -2-
LIVER FUNCTIONS TESTS -2-
 
Structure and function of erythropoietic tissue
Structure and function of erythropoietic tissueStructure and function of erythropoietic tissue
Structure and function of erythropoietic tissue
 
Drug interactions in pharmacy related practice j. bolt
Drug interactions in pharmacy related practice j. boltDrug interactions in pharmacy related practice j. bolt
Drug interactions in pharmacy related practice j. bolt
 
Liver function test
Liver function testLiver function test
Liver function test
 
Inflammatory Bowel disease ankita
Inflammatory Bowel disease ankitaInflammatory Bowel disease ankita
Inflammatory Bowel disease ankita
 
INFLAMMATORY BOWEL DISEASES
INFLAMMATORY BOWEL DISEASESINFLAMMATORY BOWEL DISEASES
INFLAMMATORY BOWEL DISEASES
 
Inflammation
InflammationInflammation
Inflammation
 
1. inflammation with vascular events dr ashutosh kumar
1. inflammation  with vascular events dr ashutosh kumar1. inflammation  with vascular events dr ashutosh kumar
1. inflammation with vascular events dr ashutosh kumar
 
Lecture 19 pancreatitis - Pathology
Lecture 19 pancreatitis - PathologyLecture 19 pancreatitis - Pathology
Lecture 19 pancreatitis - Pathology
 
Metabolic Bone Diseases Current Concept
Metabolic Bone Diseases Current ConceptMetabolic Bone Diseases Current Concept
Metabolic Bone Diseases Current Concept
 
Peptic ulcer. rubel ppt
Peptic ulcer. rubel pptPeptic ulcer. rubel ppt
Peptic ulcer. rubel ppt
 
Peptic ulcer
Peptic ulcerPeptic ulcer
Peptic ulcer
 
Inflammatory Bowel Disease
Inflammatory Bowel DiseaseInflammatory Bowel Disease
Inflammatory Bowel Disease
 
Collagen Biochemistry
Collagen BiochemistryCollagen Biochemistry
Collagen Biochemistry
 
Irritable Bowel Syndrome: An Update in Pathophysiology and Management
Irritable Bowel Syndrome: An Update in Pathophysiology and Management Irritable Bowel Syndrome: An Update in Pathophysiology and Management
Irritable Bowel Syndrome: An Update in Pathophysiology and Management
 
Inflammation lecture 4
Inflammation lecture 4Inflammation lecture 4
Inflammation lecture 4
 
Lipoprotein metabolism,
Lipoprotein metabolism, Lipoprotein metabolism,
Lipoprotein metabolism,
 
Inflammatory Bowel Disease
Inflammatory Bowel DiseaseInflammatory Bowel Disease
Inflammatory Bowel Disease
 

Semelhante a Rheumatoid arthritis _RDP

Musculoskeletal System III__Physioterapy_Spring_ 2018.ppt
Musculoskeletal System III__Physioterapy_Spring_ 2018.pptMusculoskeletal System III__Physioterapy_Spring_ 2018.ppt
Musculoskeletal System III__Physioterapy_Spring_ 2018.pptManal445405
 
RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...
RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...
RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...Prof Dr Bashir Ahmed Dar
 
RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...
RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...
RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...Prof Dr Bashir Ahmed Dar
 
TREATMENT OF RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR ...
TREATMENT OF RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR ...TREATMENT OF RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR ...
TREATMENT OF RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR ...Prof Dr Bashir Ahmed Dar
 
AUTOIMMUNE DISEASES.ppt
AUTOIMMUNE DISEASES.pptAUTOIMMUNE DISEASES.ppt
AUTOIMMUNE DISEASES.pptDrSamiyahSyeed
 
Rhemathoid arthritis RA
Rhemathoid arthritis RARhemathoid arthritis RA
Rhemathoid arthritis RAAmaal bataiha
 
AUTOIMMUNE DISEASES (1).ppt
AUTOIMMUNE DISEASES (1).pptAUTOIMMUNE DISEASES (1).ppt
AUTOIMMUNE DISEASES (1).pptDrSamiyahSyeed
 
Dissertation report
Dissertation reportDissertation report
Dissertation reportNazzma khan
 
CLINICAL CASE OF RELAPSING POLYCHONDRITIS
CLINICAL CASE OF RELAPSING POLYCHONDRITISCLINICAL CASE OF RELAPSING POLYCHONDRITIS
CLINICAL CASE OF RELAPSING POLYCHONDRITISindexPub
 
RHEUMATOID ARTHRITIS.pptx
RHEUMATOID ARTHRITIS.pptxRHEUMATOID ARTHRITIS.pptx
RHEUMATOID ARTHRITIS.pptxAmeena Kadar
 
SEPTIC ARTHRITIS-2023.pptx esp. For DCM STUDENTS
SEPTIC ARTHRITIS-2023.pptx esp. For DCM STUDENTSSEPTIC ARTHRITIS-2023.pptx esp. For DCM STUDENTS
SEPTIC ARTHRITIS-2023.pptx esp. For DCM STUDENTSMarkone7
 
Acute rheumatic fever presentation lecture
Acute rheumatic fever presentation lectureAcute rheumatic fever presentation lecture
Acute rheumatic fever presentation lectureAditiJain307041
 
Rheumatoid arthritis 2019
Rheumatoid arthritis 2019Rheumatoid arthritis 2019
Rheumatoid arthritis 2019AdesewaPearl
 

Semelhante a Rheumatoid arthritis _RDP (20)

Musculoskeletal System III__Physioterapy_Spring_ 2018.ppt
Musculoskeletal System III__Physioterapy_Spring_ 2018.pptMusculoskeletal System III__Physioterapy_Spring_ 2018.ppt
Musculoskeletal System III__Physioterapy_Spring_ 2018.ppt
 
Musculoskeletal disorders
Musculoskeletal disordersMusculoskeletal disorders
Musculoskeletal disorders
 
RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...
RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...
RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...
 
RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...
RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...
RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR MEDICINE SOPO...
 
TREATMENT OF RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR ...
TREATMENT OF RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR ...TREATMENT OF RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR ...
TREATMENT OF RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR ...
 
Sle
SleSle
Sle
 
AUTOIMMUNE DISEASES.ppt
AUTOIMMUNE DISEASES.pptAUTOIMMUNE DISEASES.ppt
AUTOIMMUNE DISEASES.ppt
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
sle Dev.pptx
sle Dev.pptxsle Dev.pptx
sle Dev.pptx
 
Rhemathoid arthritis RA
Rhemathoid arthritis RARhemathoid arthritis RA
Rhemathoid arthritis RA
 
Reh immunlogy
Reh immunlogy Reh immunlogy
Reh immunlogy
 
AUTOIMMUNE DISEASES (1).ppt
AUTOIMMUNE DISEASES (1).pptAUTOIMMUNE DISEASES (1).ppt
AUTOIMMUNE DISEASES (1).ppt
 
Dissertation report
Dissertation reportDissertation report
Dissertation report
 
CLINICAL CASE OF RELAPSING POLYCHONDRITIS
CLINICAL CASE OF RELAPSING POLYCHONDRITISCLINICAL CASE OF RELAPSING POLYCHONDRITIS
CLINICAL CASE OF RELAPSING POLYCHONDRITIS
 
Joint pathology
Joint pathologyJoint pathology
Joint pathology
 
RHEUMATOID ARTHRITIS.pptx
RHEUMATOID ARTHRITIS.pptxRHEUMATOID ARTHRITIS.pptx
RHEUMATOID ARTHRITIS.pptx
 
SEPTIC ARTHRITIS-2023.pptx esp. For DCM STUDENTS
SEPTIC ARTHRITIS-2023.pptx esp. For DCM STUDENTSSEPTIC ARTHRITIS-2023.pptx esp. For DCM STUDENTS
SEPTIC ARTHRITIS-2023.pptx esp. For DCM STUDENTS
 
Acute rheumatic fever presentation lecture
Acute rheumatic fever presentation lectureAcute rheumatic fever presentation lecture
Acute rheumatic fever presentation lecture
 
Rheumatoid arthritis 2019
Rheumatoid arthritis 2019Rheumatoid arthritis 2019
Rheumatoid arthritis 2019
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Osteomyelitis
 

Mais de rishi2789

CHEMOTHERAPY_RDP_G 5_CHLORAMPHENICOL.pdf
CHEMOTHERAPY_RDP_G 5_CHLORAMPHENICOL.pdfCHEMOTHERAPY_RDP_G 5_CHLORAMPHENICOL.pdf
CHEMOTHERAPY_RDP_G 5_CHLORAMPHENICOL.pdfrishi2789
 
CHEMOTHERAPY_RDP_G 4_CEPHALOSPORIN.pdf_SEM-6
CHEMOTHERAPY_RDP_G 4_CEPHALOSPORIN.pdf_SEM-6CHEMOTHERAPY_RDP_G 4_CEPHALOSPORIN.pdf_SEM-6
CHEMOTHERAPY_RDP_G 4_CEPHALOSPORIN.pdf_SEM-6rishi2789
 
CHEMOTHERAPY_RDP_G 3_PENICILLIN.pdf_SEM-6
CHEMOTHERAPY_RDP_G 3_PENICILLIN.pdf_SEM-6CHEMOTHERAPY_RDP_G 3_PENICILLIN.pdf_SEM-6
CHEMOTHERAPY_RDP_G 3_PENICILLIN.pdf_SEM-6rishi2789
 
CHEMOTHERAPY_RDP_GENERAL PRINCIPLES OF CHEMOTHERAPY.pdf
CHEMOTHERAPY_RDP_GENERAL PRINCIPLES OF CHEMOTHERAPY.pdfCHEMOTHERAPY_RDP_GENERAL PRINCIPLES OF CHEMOTHERAPY.pdf
CHEMOTHERAPY_RDP_GENERAL PRINCIPLES OF CHEMOTHERAPY.pdfrishi2789
 
Drug use in Thyroid and Anti Thyroid analogue.pptx
Drug use in Thyroid and Anti Thyroid analogue.pptxDrug use in Thyroid and Anti Thyroid analogue.pptx
Drug use in Thyroid and Anti Thyroid analogue.pptxrishi2789
 
Basic concept of Endocrine pharmacology.pptx
Basic concept of Endocrine pharmacology.pptxBasic concept of Endocrine pharmacology.pptx
Basic concept of Endocrine pharmacology.pptxrishi2789
 
RISHITA_M.PHARM_CS.pptx
RISHITA_M.PHARM_CS.pptxRISHITA_M.PHARM_CS.pptx
RISHITA_M.PHARM_CS.pptxrishi2789
 
MEDICAL RESEARCH.pptx
MEDICAL RESEARCH.pptxMEDICAL RESEARCH.pptx
MEDICAL RESEARCH.pptxrishi2789
 
ANTI RA AGENTS.pptx
ANTI RA AGENTS.pptxANTI RA AGENTS.pptx
ANTI RA AGENTS.pptxrishi2789
 
Leukotrines.pdf
Leukotrines.pdfLeukotrines.pdf
Leukotrines.pdfrishi2789
 
5-HT and their Antagonist.pdf
5-HT and their Antagonist.pdf5-HT and their Antagonist.pdf
5-HT and their Antagonist.pdfrishi2789
 
Introduction to Autocids And Histamine and Antihistamine.pdf
Introduction to Autocids And Histamine and Antihistamine.pdfIntroduction to Autocids And Histamine and Antihistamine.pdf
Introduction to Autocids And Histamine and Antihistamine.pdfrishi2789
 
RDP-CP-PP.pdf
RDP-CP-PP.pdfRDP-CP-PP.pdf
RDP-CP-PP.pdfrishi2789
 
NEW DRUG DEVELOPMENT_RDP_2023.pdf
NEW DRUG DEVELOPMENT_RDP_2023.pdfNEW DRUG DEVELOPMENT_RDP_2023.pdf
NEW DRUG DEVELOPMENT_RDP_2023.pdfrishi2789
 
ADR-RDP-2023.pdf
ADR-RDP-2023.pdfADR-RDP-2023.pdf
ADR-RDP-2023.pdfrishi2789
 
RDP_PORTION ONLY_Question Bank_HAP-I_2023.pdf
RDP_PORTION ONLY_Question Bank_HAP-I_2023.pdfRDP_PORTION ONLY_Question Bank_HAP-I_2023.pdf
RDP_PORTION ONLY_Question Bank_HAP-I_2023.pdfrishi2789
 
Introduction to human body_RDP.pdf
Introduction to human body_RDP.pdfIntroduction to human body_RDP.pdf
Introduction to human body_RDP.pdfrishi2789
 
RDP-PP-MA.pdf
RDP-PP-MA.pdfRDP-PP-MA.pdf
RDP-PP-MA.pdfrishi2789
 
PATIENT COUNSELLING_RDP.pdf
PATIENT COUNSELLING_RDP.pdfPATIENT COUNSELLING_RDP.pdf
PATIENT COUNSELLING_RDP.pdfrishi2789
 

Mais de rishi2789 (20)

CHEMOTHERAPY_RDP_G 5_CHLORAMPHENICOL.pdf
CHEMOTHERAPY_RDP_G 5_CHLORAMPHENICOL.pdfCHEMOTHERAPY_RDP_G 5_CHLORAMPHENICOL.pdf
CHEMOTHERAPY_RDP_G 5_CHLORAMPHENICOL.pdf
 
CHEMOTHERAPY_RDP_G 4_CEPHALOSPORIN.pdf_SEM-6
CHEMOTHERAPY_RDP_G 4_CEPHALOSPORIN.pdf_SEM-6CHEMOTHERAPY_RDP_G 4_CEPHALOSPORIN.pdf_SEM-6
CHEMOTHERAPY_RDP_G 4_CEPHALOSPORIN.pdf_SEM-6
 
CHEMOTHERAPY_RDP_G 3_PENICILLIN.pdf_SEM-6
CHEMOTHERAPY_RDP_G 3_PENICILLIN.pdf_SEM-6CHEMOTHERAPY_RDP_G 3_PENICILLIN.pdf_SEM-6
CHEMOTHERAPY_RDP_G 3_PENICILLIN.pdf_SEM-6
 
CHEMOTHERAPY_RDP_GENERAL PRINCIPLES OF CHEMOTHERAPY.pdf
CHEMOTHERAPY_RDP_GENERAL PRINCIPLES OF CHEMOTHERAPY.pdfCHEMOTHERAPY_RDP_GENERAL PRINCIPLES OF CHEMOTHERAPY.pdf
CHEMOTHERAPY_RDP_GENERAL PRINCIPLES OF CHEMOTHERAPY.pdf
 
Drug use in Thyroid and Anti Thyroid analogue.pptx
Drug use in Thyroid and Anti Thyroid analogue.pptxDrug use in Thyroid and Anti Thyroid analogue.pptx
Drug use in Thyroid and Anti Thyroid analogue.pptx
 
Basic concept of Endocrine pharmacology.pptx
Basic concept of Endocrine pharmacology.pptxBasic concept of Endocrine pharmacology.pptx
Basic concept of Endocrine pharmacology.pptx
 
RISHITA_M.PHARM_CS.pptx
RISHITA_M.PHARM_CS.pptxRISHITA_M.PHARM_CS.pptx
RISHITA_M.PHARM_CS.pptx
 
MEDICAL RESEARCH.pptx
MEDICAL RESEARCH.pptxMEDICAL RESEARCH.pptx
MEDICAL RESEARCH.pptx
 
ANTI RA AGENTS.pptx
ANTI RA AGENTS.pptxANTI RA AGENTS.pptx
ANTI RA AGENTS.pptx
 
NSAIDS.pptx
NSAIDS.pptxNSAIDS.pptx
NSAIDS.pptx
 
Leukotrines.pdf
Leukotrines.pdfLeukotrines.pdf
Leukotrines.pdf
 
5-HT and their Antagonist.pdf
5-HT and their Antagonist.pdf5-HT and their Antagonist.pdf
5-HT and their Antagonist.pdf
 
Introduction to Autocids And Histamine and Antihistamine.pdf
Introduction to Autocids And Histamine and Antihistamine.pdfIntroduction to Autocids And Histamine and Antihistamine.pdf
Introduction to Autocids And Histamine and Antihistamine.pdf
 
RDP-CP-PP.pdf
RDP-CP-PP.pdfRDP-CP-PP.pdf
RDP-CP-PP.pdf
 
NEW DRUG DEVELOPMENT_RDP_2023.pdf
NEW DRUG DEVELOPMENT_RDP_2023.pdfNEW DRUG DEVELOPMENT_RDP_2023.pdf
NEW DRUG DEVELOPMENT_RDP_2023.pdf
 
ADR-RDP-2023.pdf
ADR-RDP-2023.pdfADR-RDP-2023.pdf
ADR-RDP-2023.pdf
 
RDP_PORTION ONLY_Question Bank_HAP-I_2023.pdf
RDP_PORTION ONLY_Question Bank_HAP-I_2023.pdfRDP_PORTION ONLY_Question Bank_HAP-I_2023.pdf
RDP_PORTION ONLY_Question Bank_HAP-I_2023.pdf
 
Introduction to human body_RDP.pdf
Introduction to human body_RDP.pdfIntroduction to human body_RDP.pdf
Introduction to human body_RDP.pdf
 
RDP-PP-MA.pdf
RDP-PP-MA.pdfRDP-PP-MA.pdf
RDP-PP-MA.pdf
 
PATIENT COUNSELLING_RDP.pdf
PATIENT COUNSELLING_RDP.pdfPATIENT COUNSELLING_RDP.pdf
PATIENT COUNSELLING_RDP.pdf
 

Último

Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfMr Bounab Samir
 
Science 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxScience 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxMaryGraceBautista27
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptxmary850239
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxiammrhaywood
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxHumphrey A Beña
 
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxGrade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxChelloAnnAsuncion2
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPCeline George
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...JhezDiaz1
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptxSherlyMaeNeri
 
Gas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxGas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxDr.Ibrahim Hassaan
 
Q4 English4 Week3 PPT Melcnmg-based.pptx
Q4 English4 Week3 PPT Melcnmg-based.pptxQ4 English4 Week3 PPT Melcnmg-based.pptx
Q4 English4 Week3 PPT Melcnmg-based.pptxnelietumpap1
 
DATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersDATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersSabitha Banu
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Celine George
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxAnupkumar Sharma
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfAMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfphamnguyenenglishnb
 

Último (20)

Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
 
Science 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxScience 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptx
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
 
Raw materials used in Herbal Cosmetics.pptx
Raw materials used in Herbal Cosmetics.pptxRaw materials used in Herbal Cosmetics.pptx
Raw materials used in Herbal Cosmetics.pptx
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
 
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptxGrade 9 Q4-MELC1-Active and Passive Voice.pptx
Grade 9 Q4-MELC1-Active and Passive Voice.pptx
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERP
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptx
 
Gas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxGas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptx
 
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptxYOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
YOUVE_GOT_EMAIL_PRELIMS_EL_DORADO_2024.pptx
 
Q4 English4 Week3 PPT Melcnmg-based.pptx
Q4 English4 Week3 PPT Melcnmg-based.pptxQ4 English4 Week3 PPT Melcnmg-based.pptx
Q4 English4 Week3 PPT Melcnmg-based.pptx
 
DATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersDATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginners
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfAMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
 

Rheumatoid arthritis _RDP

  • 2.  Rheumatoid arthritis (RA) is a chronic inflammatory disorder of autoimmune origin that may affect many tissues and organs but principally attacks the joints, producing a nonsuppurative proliferative and inflammatory synovitis.  RA often progresses to destruction of the articular cartilage and ankylosis of the joints.
  • 3.  Extraarticular lesions may involve skin, heart, blood vessels and lungs.  The prevalence in the United States is approximately 1%.  In India, estimated prevalence rate of RA is 0.5%–0.75%.[25-Aug-2020]  The disease peaks in the second to fourth decades and is three times more common in women than men.
  • 4.  systemic manifestations include haematologic, pulmonary, neurological and cardiovascular abnormalities.  ETIOPATHOGENESIS On based on etiology and pathogenesis proposes that RA occurs in an immunogenetically predisposed individual to the effect of microbial agents acting as trigger antigen. The role of superantigens which are produced by several microorganisms with capacity to bind to susceptible gene [HLA-DR molecules (MHC-II region)] has also emerged.
  • 5.  A number of observations in research indicates the role of immune processes, particularly autoimmune phenomenon, in the development of RA. These include the following: 1. Detection of circulating autoantibody called rheumatoid factor (RF) against Fc portion of autologous IgG in about 80% cases of RA. RF antibodies are heterogeneous and consist of IgM and IgG class. 2. The presence of antigen-antibody complexes (IgG-RF complexes) in the circulation as well as in the synovial fluid. 3. The presence of other autoantibodies such as antinuclear factor (ANF), antibodies to collagen type II, and antibodies to cytoskeleton.
  • 6. 4. Antigenicity of proteoglycans of human articular cartilage. 5. The presence of g-globulin, particularly IgG and IgM, in the synovial fluid. 6. Association of RA with amyloidosis. 7. Activation of cell-mediated immunity as observed by presence of numerous inflammatory cells in the synovium, chiefly CD4+ T lymphocytes and some macrophages.
  • 7.  Though the above hypothesis of a possible role of autoimmunity in the etiology and pathogenesis of RA is generally widely accepted, controversy continues as regards the trigger events which initiate the destruction of articular cartilage. Various possibilities which have been suggested are as follows: 1. The existence of an infectious agent such as mycoplasma, Epstein-Barr virus (EBV), cytomegalovirus (CMV) or rubella virus, either locally in the synovial fluid or systemic infection some time prior to the attack of RA. 1. The possible role of HLA-DR4 and HLA-DR1 in initiation of immunologic damage.
  • 8. i) In response to antigenic exposure (e.g. infectious agent) in a genetically predisposed individual (HLA-DR), CD4+ T-cells are activated. ii) These cells elaborate cytokines, the important ones being tumour necrosis factor (TNF)-a, interferon (IF)-g, interleukin (IL)-1 and IL-6. iii) These cytokines activate endothelial cells, B lymphocytes and macrophages. iv) Activation of B-cells releases IgM antibody against IgG (i.e. anti-IgG); this molecule is termed rheumatoid factor (RF).
  • 9. v) IgG and IgM immune complexes trigger inflammatory damage to the synovium, small blood vessels and collagen. vi) Activated endothelial cells express adhesion molecules which stimulate collection of inflammatory cells. vii)Activation of macrophages releases more cytokines which cause damage to joint tissues and vascularisation of cartilage termed pannus formation. viii)Eventually damage and destruction of bone and cartilage are followed by fibrosis and ankylosis producing joint deformities.
  • 10.
  • 11.  The predominant pathologic lesions are found in the joints and tendons, and less often, extra-articular lesions are encountered.  ARTICULAR LESIONS RA involves first the small joints of hands and feet and then symmetrically affects the joints of wrists, elbows, ankles and knees. The proximal interphalangeal and metacarpophalangeal joints are affected most severely. Frequently cervical spine is involved but lumbar spine is spared
  • 12.
  • 13.  The characteristic feature is diffuse proliferative synovitis with formation of pannus. The microscopic changes are as under 1. Numerous folds of large villi of synovium. 2. Marked thickening of the synovial membrane due to oedema, congestion and multilayering of synoviocytes. 3. Intense inflammatory cell infiltrate in the synovial membrane with predominance of lymphocytes, plasma cells and some macrophages, at places forming lymphoid follicles. 4. Foci of fibrinoid necrosis and fibrin deposition.
  • 14.  The pannus progressively destroys the underlying cartilage and subchondral bone.  This invasion of pannus results in demineralisation and cystic resorption of underlying bone.  Later, fibrous adhesions or even bony ankylosis may unite the two opposing joint surfaces.  In addition, persistent inflammation causes weakening and even rupture of the tendons.
  • 15.
  • 16.  Nonspecific inflammatory changes are seen in the blood vessels (acute vasculitis), lungs, pleura, pericardium, myocardium, lymph nodes, peripheral nerves and eyes.  But one of the characteristic extra-articular manifestation of RA is occurrence of rheumatoid nodules in the skin.  Rheumatoid nodules are particularly found in the subcutaneous tissue over pressure points such as the elbows, occiput and sacrum.  Similar nodules may be found in the lung parenchyma, pleura, heart valves, myocardium and other internal organs.
  • 17.
  • 18.
  • 19.
  • 20. 1. Juvenile RA found in adolescent patients under 16 years of age is characterised by acute onset of fever and predominant involvement of knees and ankles. Pathologic changes are similar but RF is rarely present. 1. Felty’s syndrome consists of polyarticular RA associated with splenomegaly and hypersplenism and consequent haematologic derangements. 2. Ankylosing spondylitis or rheumatoid spondylitis is rheumatoid involvement of the spine, particularly sacroiliac joints, in young male patients. The condition has a strong HLA-B27 association and may have associated inflammatory diseases such as inflammatory bowel disease, anterior uveitis and Reiter’s syndrome.

Notas do Editor

  1. Ankylosis: abnormal immobility of a joint from a fibrous or bony union due to disease, injury, or a surgical procedure. Suppuration: pus formation.
  2. Human Leukocyte Antigen – DR isotype ,  Class II major histocompatibility complex molecules present on the surface of antigen expressing cell.
  3. the fragment crystallizable region (Fc region) is the tail region of an antibody that interacts with cell surface receptors called Fc receptors, ANF: Autoantibody
  4. amyloidosis (am-uh-loi-DO-sis) is a rare disease that occurs when an abnormal protein, called amyloid, builds up in your organs and interferes with their normal function.
  5. Ankylosis is a stiffness of a joint due to abnormal adhesion and rigidity of the bones of the joint, which may be the result of injury or disease.
  6. pannus: a mass of edematous synovium, inflammatory cells, granulation tissue, and fibroblasts that grows over the articular cartilage and causes its erosion. In time, after the cartilage has been destroyed, the pannus bridges the apposing bones to form a fibrous ankylosis, which eventually ossifies and results in fusion of the bones, called bony ankylosis
  7. Felty's syndrome is a rare, potentially serious disorder that is defined by the presence of three conditions: rheumatoid arthritis (RA), an enlarged spleen (splenomegaly) and a decreased white blood cell count (neutropenia), which causes repeated infections.